Activation of autoreactive T cells by peptides from human pathogens

Current Opinion in Immunology

Volumn 9, Issue 6, 1997, Pages 831-838

  Hausmann, Stefan ^a   Wucherpfennig, Kai W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; VIRUS PROTEIN;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN SPECIFICITY; AUTOIMMUNITY; CROSS REACTION; HUMAN; HUMAN CELL; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0031460674     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80186-0     Document Type: Article

References (57)

1. Kersh GJ, Allen PM: Essential flexibility in the T-cell recognition of antigen. Nature 1996, 380:495-498.
2. Evavold BD, Sloan-Lancaster J, Wilson KJ, Rothbard JB, Allen PM: Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 1995, 2:655-663.
3. Wucherpfennig KW, Strominger JL: Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995, 80:695-705.
4. Oldstone MBA: Molecular mimicry and autoimmune disease. Cell 1987, 50:819-820.
5. Davies JM: Molecular mimicry: can epitope mimicry induce autoimmune disease? Immunol Cell Biol 1997, 75:113-126.
6. Chicz RM, Urban RG, Gorga JC, Vignali DAA, Lane WS, Strominger JL: Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 1993, 178:27-47.
7. Rammensee H-G, Friede T, Stevanovic S: MHC ligands and peptide motifs: first listing. Immunogenetics 1995, 41:178-228.
8. Reay PA, Kantor RM, Davis MM: Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J Immunol 1994, 152:3946-3957,
9. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC: Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 1996, 384:134-141. The crystal structure of a TCR-peptide-MHC molecular complex demonstrates the diagonal position of the TCR on the MHC molecule-peptide complex. The small TCR contact surface with the MHC molecule-bound peptide indicates that there is a physical limit to the specificity of a TCR.
10. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, Wilson IA: An αβT cell receptor structure at 2.5 Ȧ and its orientation in the TCR-MHC complex. Science 1996,274:209-219. The crystal structure of a murine TCR and its orientation on the MHC molecule-peptide complex are described. The same diagonal orientation as with the human HLA-A2 restricted TCR was observed.
11. Burrows SR, Silins SL, Khanna R, Burrows JM, Rischmueller M, McCluskey J, Moss DJ: Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in allorecognition. Bur J Immunol 1997, 27:1726-1736.
12. d-presented allopeptide, illustrates the flexibility of TCR recognition.
13. Udaka K, Wiesmüller K-H, Kienle S, Jung G, Walden P: Self-MHC-restricted peptides recognized by an alloreactive T lymphocyte clone. J Immunol 1996, 157:670-678.
14. + T-cell clone. Proc Natl Acad Sci USA 1993, 90:11272-11276.
15. Brock R, Wiesmüller K-H, Jung G, Walden P: Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor. Proc Natl Acad Sci USA 1996, 93:13108-13113.
16. Loftus DJ, Chen Y, Covell DG, Engelhard VH, Appella E: Differential contact of disparate class l/peptide complexes as the basis for epitope cross-recognition by a single T cell receptor. J Immunol 1997, 158:3651-3658. The analysis of the fine specificity of a murine xenoreactive HLA-A2-specific T cell clone reveals differences in the relative importance of peptide side chains for TCR recognition in different MHC molecule-peptide complexes. This implies that a single TCR is able to use differential contact sites for recognition.
17. Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, Robertson N, Clayton D, Goodfellow PN, Compston A: A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996, 13:464-468.
18. The Multiple Sclerosis Genetics Group: A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat Genet 1996, 13:469-471.
19. Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G, Anderson C, Armstrong H, Cousin K, Bell RB, Hader W et al.: A full genome search in multiple sclerosis. Nat Genet 1996, 13:472-476.
20. Kurzke JF: Epidemiology of multiple sclerosis. In Handbook of Clinical Neurology. Edited by Vinken PJ, Bruyn HL, Klawans HL, Koetsier JC. Amsterdam/New york: Elsevier Science: 1985.
21. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA: T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990, 346:183-187.
22. Martin R, Jaraquemada D, Flerlage M, Richert J, Whitaker J, Long EO, McFarlin DE, Mcfarland HF: Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol 1990, 145:540-548.
23. Pette M, Fujita K, Wilkinson D, Altmann DM, Trowsdale J, Giegerich G, Hinkkanen A, Epplen JT, Kappos L, Wekerle H: Myelin autoreactivity in multiple sclerosis: recognition of myek=lin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors. Proc Natl Acad Sci USA 1990, 87:7968-7972.
24. Wucherpfennig KW, Zhang J, Witek C, Matsui M, Modabber Y, Ota K, Hafler DA: Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol 1994, 152:5581-5592.
25. Wucherpfennig KW, Sette A, Southwood S, Oseroff C, Matsui M, Strominger JL, Hafler DA: Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J Exp Med 1994, 179:279-290.
26. Wucherpfennig KW, Hafler DA, Strominger JL: Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes. Proc Natl Acad Sci USA 1995, 92:8896-8900.
27. Vergelli M, Hemmer B, Kalbus M, Vogt AB, Ling N, Conlon P, Coligan JE, McFarland H, Martin R: Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells. J Immunol 1997, 158:3746-3752.
28. Ausubel LJ, Kwan CK, Sette A, Kuchroo V, Hafler DA: Complementary mutations in an antigenic peptide allow for crossreactivity of autoreactive T-cell clones. Proc Natl Acad Sci USA 1996,93:15317-15322. This study shows that the combination of two nonstimulatory substitutions in the MBP(85-99) peptide in a double substituted analog can restore the activation of some MBP-specific T cell clones. This illustrates the combinatorial effects of multiple substitutions on T cell activation by peptide analogs.
29. Hemmer B, Fleckenstein BT, Vergelli M, Jung G, McFarland H, Martin R, Wiesmüller K-H: Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J Exp Med 1997, 185:1651-1659. The fine specificity of a highly degenerate myelin basic protein-specific T cell clone - MBP(88-98) specific - is analyzed using random peptide libraries. Based on that motif several peptides of human and microbial origin were identified that can activate this autoreactive clone.
30. Warren KG, Cate I, Steinman L: Fine specificity of the antibody response to myelin basic protein in the central nervous system in multiple sclerosis: the minimal B-cell epitope and a model of its features. Proc Natl Acad Sci USA 1995, 92:11061-11065.
31. Wucherpfennig KW, Catz I, Hausmann S, Strominger JL, Steinman L, Warren KG: Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2 restricted T-cell clones from multiple sclerosis patients: identity of key contact residues in the B-cell and T-cell epitopes. J Clin Invest 1997, 100:1114-1122. The fine specificity of myelin basic protein (MBP)-specific antibodies that were purified from brains multiple sclerosis patients was compared to MBP specific T cell clones. Residues that were critical for both antibody binding and T cell receptor recognition were located in a 10 amino acid segment. A viral peptide was identified that was bound by purified autoantibodies and that also stimulated a MBP specific T cell clone.
32. Talbot PJ, Paquette J-S, Ciurli C, Antel JP, Ouellet F: Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Ann Neurol 1996, 39:233-240.
33. Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM: Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993, 72:551-560.
34. Brabb T, Goldrath AW, von Dassow P, Paez A, Liggitt HD, Goverman J: Triggers of autoimmune disease in a murine TCR-transgenic model for multiple sclerosis. J Immunol 1997, 159:497-507. The increased incidence of spontaneous experimental autoimmunoe encephatomyelitis in TCR transgenic mice under non-germ free conditions demonstrates the impact of the microbial environment on the induction of autoimmunity. Further studies on these transgenic mice show that following T cell activation in vivo the entry of the autoreactive MBP-specific T cells into the central nervous system is a critical step for the initiation of the autoimmune disease.
35. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernandez-Sueiro JL, Balish E, Hammer RE: The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994, 180:2359-2364.
36. Fujinami RS, Oldstone MBA: Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985, 230:1043-1045.
37. Gautam AM, Pearson CI, Smilek DE, Steinman L, McDevitt HO: A polyalanine peptide with only five native myelin basic protein residues induces autoimmune encephalomyelitis. J Exp Med 1992, 176:605-609.
38. Gautam AM, Lock CB, Smilek DE, Pearson Cl, Steinman L, McDevitt HO: Minimal structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunity. Proc Natl Acad Sci USA 1994, 91:767-771.
39. Singh VK, Nagaraju K: Experimental autoimmune uveitis: molecular mimicry and oral tolerance. Immunol Res 1996, 15:323-346.
40. Garza KM, Tung KSK: Frequency of molecular mimicry among T cell peptides as the basis for autoimmune disease and autoantibody induction. J Immunol 1995, 155:5444-5448.
41. Van Eden W, Hogervorst EJM, Hensen EJ, van der Zee R, van Embden JDA, Cohen IR: A cartilage-mimicking T-cell epitope on a 65K mycobacterial heat shock protein: adjuvant arthritis as a model for human rheumatoid arthritis. Curr Top Microbiol Immunol 1989, 145:27-43.
42. Billingham MEJ, Carney S, Butler R, Colston MJ: A mycobacterial 65-kD heat shock protein induces antigen-specific suppression of adjuvant arthritis, but is not itself arthritogenic. J Exp Med 1990, 171:339-344.
43. Moudgil KD, Chang TT, Eradat H, Chen AM, Gupta RS, Brahn E, Sercarz EE: Diversification of T cell responses to carboxy-terminal determinants within the 65-kD heat-shock protein is involved in regulation of autoimmune arthritis. J Exp Med 1997, 185:1307-1316.
44. Von Herrath MG, Oldstone MBA: Virus-induced autoimmune disease. Curr Opin Immunol 1996, 8:878-885.
45. Ohashi PS, Oehen S, Buerki K, Pircher H, Ohashi CT, Odermatt B, Malissen B, Zinkernagel RM, Hengartner H: Ablation of 'tolerance' and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991, 65:305-317.
46. Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H: Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991, 65:319-331.
47. Evans CF, Horwitz MS, Hobbs MV, Oldstone MBA: Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease. J Exp Med 1996, 184:2371-2384. Transgenic mice, expressing a viral protein in oligodendrocytes, exhibit signs of central nervous autoimmunity, although no EAE, after infection with the corresponding virus.
48. Von Herrath MG, Allison J, Miller JFAP, Oldstone MBA: Focal expression of interleukin-2 does not break unresponsiveness to 'self (viral) antigen expressed in β cells but enhances development of autoimmune disease (diabetes) after initiation of an anti-self immune response. J Clin Invest 1995, 95:477-485.
49. Lee M-S, von Herrath M, Reiser H, Oldstone MBA, Sarvetnick N: Sensitization of self (virus) antigen by in situ expression of murine interferon-γ. J Clin Invest 1995, 95:486-492.
50. Von Herrath MG, Oldstone MBA: Interferon-γ is essential for destruction of β cells and development of insulin-dependent diabetes mellitus. J Exp Med 1997, 185:531-539.
51. Von Herrath MG, Guerder S, Lewicki H, Flavell RA, Oldstone MBA: Coexpression of B7-1 and viral ('self') transgenes in pancreatic β cells can break peripheral ignorance and lead to spontaneous autoimmune disease. Immunity 1995, 3:727-738.
52. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SCL, Jenkins SC, Palmer SM et al.: A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994, 371:130-136.
53. Atkinson MA, Bowman MA, Campbell L, Darrow BL, Kaufman DL, Maclaren NK: Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependent diabetes. J Clin Invest 1994, 94:2125-2129.
54. Quayle AJ, Wilson KB, Li SG, Kjeldsen-Kragh J, Oftung F, Shinnick T, Sioud M, Forre O, Capra JD, Natvig JB: Peptide recognition, T cell receptor usage and HLA restriction elements of human heat-shock protein (hsp) 60 and mycobacterial 65-kDa hsp-reactive T cell clones from rheumatoid synovial fluid. Eur J Immunol 1992, 22:1315-1322.
55. Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y: HLA DRB4*0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune disease. J Exp Med 1995, 181:1835-1845.
56. Tian J, Lehmann PV, Kaufman DL: T cell cross-reactivity between Coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J Exp Med 1994, 180:1979-1984.
57. Zügel U, Schoel B, Yamamoto S, Hengel H, Morein B, Kaufmann SHE: Crossrecognition by CD8 T cell receptor αβ cytotoxic T lymphocytes of peptides in the self and the mycobacterial hsp60 which share intermediate sequence homology. Eur J Immunol 1995, 25:451-458.